279.13
-2.15%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About APT Medical
Its shares trade on Shanghai under the ticker 688617.SS. It has been listed since 7 January 2021. In the fiscal year to 31 December 2025, it reported revenue of CN¥2.58bn and net income of CN¥820.6m. At that date it held total assets of CN¥3.66bn and shareholders' equity of CN¥3.09bn.
APT Medical, Inc. engages in the research, development, production, and sale of electrophysiology, coronary access, and peripheral vascular intervention medical devices. The company is headquartered in Shenzhen, Guangdong. The company went IPO on 2021-01-07. The firm's electrophysiological products include electrophysiological electrode catheters, controllable radiofrequency ablation electrode catheters and multichannel electrophysiological systems. Its coronary artery access products mainly include guide wires, micro catheters, balloons, contrast guide wires and catheters. The firm's peripheral vascular intervention products are mainly applied in peripheral vascular diseases. The firm is also engaged in related original equipment manufacturer (OEM) business. The firm distributes its products within domestic market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 7 Jan 2021
- Employees
- 1,743
- Website
- aptmed.com ↗
Leadership
Pay as last reported
- Mr. Zhenghui ChengChairman of the Board, General Manager, since 2014CN¥3.3m
- Mr. Zhenhua DaiFinance Director, Deputy General Manager, Secretary of the Board, Director, since 2013CN¥2.5m
- Mr. Yiqing XuDeputy General Manager, Director, since 2006CN¥1.0m
- Mr. Yonggui HanDeputy General ManagerCN¥1.4m
- Mr. Fangyuan LiuDeputy General ManagerCN¥1.4m
- Mr. Yuchen QiuDeputy General ManagerCN¥1.3m
- Mr. Jinhe WangDeputy General ManagerCN¥1.7m
- Mr. Wei WangDeputy General ManagerCN¥1.4m
- Ms. Jing XuDirector
- Mr. Lijun XiaIndependent DirectorCN¥180,000
- Mr. Yuefeng XiaoIndependent DirectorCN¥180,000
- Mr. Yuanxiang ZhuIndependent DirectorCN¥180,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 51
- Environment
- 52
- Social
- 77
- Governance
- 25
- Direct emissions (scope 1)
- 597.65 t
- Energy emissions (scope 2)
- 14,048.07 t
- Women in the workforce
- 60.47%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- APT Medical's electrophysiology products include electrode catheters and radiofrequency ablation systems.
- The company employs 1,743 full-time employees in Shenzhen, China.
- APT Medical distributes products domestically and to overseas markets.
Weaknesses
- APT Medical's OEM business is limited to specific medical device segments.
- The company's coronary access products include guide wires and micro catheters.
- The firm's peripheral vascular intervention products are applied in peripheral vascular diseases.
Opportunities
- APT Medical's electrophysiology products are used in electrophysiological systems.
- The company's coronary artery access products are distributed to overseas markets.
- APT Medical's peripheral vascular intervention products target peripheral vascular diseases.
Threats
- APT Medical's electrophysiology products face competition in the Health Care sector.
- The company's coronary access products are subject to market fluctuations.
- The firm's peripheral vascular intervention products are affected by regulatory changes.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.